Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$82,244
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-10-13 SAYARE MITCHEL Director Grant or award · Stock Options (option to buy) +20,000 20,000
2017-10-13 SCHAFFER DERACE L Director Grant or award · Stock Options (option to buy) +20,000 20,000
2017-10-13 Schafer Klaus Director Grant or award · Stock Options (option to buy) +20,000 20,000
2017-10-13 GILL JOHN Director Grant or award · Stock Options (option to buy) +20,000 20,000
2017-10-13 Drutz David Director Grant or award · Stock Options (option to buy) +20,000 20,000
2017-10-13 Hodges Philip Director Grant or award · Stock Options (option to buy) +20,000 20,000
2017-09-22 Tasker Sybil Chief Medical Officer Grant or award · Stock Options (option to buy) +50,000 50,000
2017-09-22 Roberts M Scot Chief Scientific Officer Grant or award · Stock Options (option to buy) +50,000 50,000
2017-09-22 Enright William President and CEO Grant or award · Stock Options (option to buy) +125,000 125,000
2017-09-22 CZEREPAK ELIZABETH CFO and EVP Corp. Development Grant or award · Stock Options (option to buy) +62,500 62,500
2017-09-22 CZEREPAK ELIZABETH CFO and EVP Corp. Development Grant or award · Stock Options (option to buy) +62,500 62,500
2017-08-25 SCHAFFER DERACE L Director Purchase +50,000 $2.25 $112K 221,704
2017-08-24 SCHAFFER DERACE L Director Purchase +17,326 $2.24 $39K 171,704
2017-08-23 Drutz David Director Purchase +5,000 $2.27 $11K 30,777
2017-08-23 SCHAFFER DERACE L Director Purchase +43,352 $2.22 $96K 154,378
2017-08-22 Drutz David Director Purchase +5,000 $2.15 $11K 25,777
2017-08-22 SCHAFFER DERACE L Director Purchase +5,958 $2.10 $13K 111,026
2017-08-21 SCHAFFER DERACE L Director Purchase +690 $2.02 $1K 105,068
2017-08-21 Truffle Capital S.A.S. 10% owner Purchase · Series B Convertible Preferred Stock +204.89 $940.00 $193K 204.89
2017-08-21 Truffle Capital S.A.S. 10% owner Purchase · Series B Convertible Preferred Stock +273.19 $940.00 $257K 273.19

Page 30 of 43 · 845 trades